Statistical analysis results indicated that patients carrying haplotype G-A (rs6721961–rs6726395, in NRF2) had a lower risk of HCC (OR = 0.700, 95% CI: 0.508–0.965, P = 0.028) (Table 3). The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.